| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9942446 | The American Journal of the Medical Sciences | 2005 | 5 Pages |
Abstract
Increased urinary L-FABP levels may be associated with the development of ADPKD, and candesartan cilexetil has a beneficial effect on reducing these levels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tsukasa MD, Yasuhiro MD, Takeshi MD, Hikaru MD, Yoshihiko MD, Shiwori MD,